Clinical Trials Browser

Recruiting × Hearing Loss × 1 year × Clear all

NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Phase 1 Recruiting

Testicular Neoplasms, Seminoma, Hearing Loss

NCT06517888 2026-04-06

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 1/2 Recruiting

Neuroma, Acoustic, Hearing Loss

NCT04915183 2026-03-09

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT07420751 2026-02-20

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Phase NA Recruiting

Neurofibromatosis 2, Hearing Loss

NCT06781749 2026-01-13

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

Dementia, Hearing Loss

NCT05582551 2025-12-22

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Phase NA Recruiting

Neoplasms, Peripheral Nervous System Diseases, Hearing Loss

NCT06303180 2025-11-14

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Head and Neck Neoplasms, Hearing Disorders, Laryngeal Diseases, Speech, Hearing Loss

NCT02310399 2025-10-30

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Phase NA Recruiting

Deafness, Hearing Loss